We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
-18.72%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$852M
AUM Growth
-$2.71B
Cap. Flow
-$2.35B
Cap. Flow %
-275.82%
Top 10 Hldgs %
41.33%
Holding
1,001
New
100
Increased
48
Reduced
168
Closed
613

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$24.8M
2
BHC icon
Bausch Health
BHC
+$12.4M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$12.3M
4
NFLX icon
Netflix
NFLX
+$10.3M
5
TNET icon
TriNet
TNET
+$9.7M

Sector Composition

Rank Sector Weight
1 Healthcare 1.87%
2 Energy 1.43%
3 Technology 0.91%
4 Real Estate 0.26%
5 Communication Services 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANET icon
176
CALL
Arista Networks
ANET
$226B
$656K 0.08%
28,000
-159,200
-85% -$4.37M
PLAY icon
177
PUT
Dave & Buster's
PLAY
$375M
$656K 0.08%
20,000
-2,900
-13% -$116K
MMSI icon
178
PUT
Merit Medical Systems
MMSI
$5.07B
$651K 0.08%
+12,000
New +$732K
RVLV icon
179
Revolve Group
RVLV
$1.82B
$648K 0.08%
25,000
+18,000
+257% +$665K
ARQT icon
180
PUT
Arcutis Biotherapeutics
ARQT
$3.37B
$639K 0.08%
30,000
+15,000
+100% +$308K
GBT
181
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$639K 0.08%
+20,000
New +$585K
PFSI icon
182
CALL
PennyMac Financial
PFSI
$3.88B
$634K 0.07%
+14,500
New +$685K
LONA
183
CALL
LeonaBio Inc
LONA
$68.5M
$628K 0.07%
20,600
+2,620
+15% +$240K
IMAX icon
184
CALL
IMAX
IMAX
$2.61B
$628K 0.07%
37,200
AXSM icon
185
PUT
Axsome Therapeutics
AXSM
$11.6B
$617K 0.07%
+16,100
New +$509K
FANG icon
186
Diamondback Energy
FANG
$56.7B
$606K 0.07%
5,000
-47,700
-91% -$6.54M
GM icon
187
CALL
General Motors
GM
$79.5B
$603K 0.07%
19,000
-1,000
-5% -$37.5K
IBB icon
188
PUT
iShares Biotechnology ETF
IBB
$9.36B
$588K 0.07%
+5,000
New +$594K
CCCC icon
189
CALL
C4 Therapeutics
CCCC
$395M
$585K 0.07%
77,600
VAC icon
190
CALL
Marriott Vacations Worldwide
VAC
$3.38B
$581K 0.07%
5,000
MJ icon
191
CALL
Amplify Alternative Harvest ETF
MJ
$101M
$580K 0.07%
8,333
VVV icon
192
CALL
Valvoline
VVV
$4.89B
$577K 0.07%
20,000
-240,000
-92% -$7.37M
MRK icon
193
CALL
Merck
MRK
$319B
$574K 0.07%
6,300
-72,800
-92% -$6.45M
BRK.B icon
194
PUT
Berkshire Hathaway Class B
BRK.B
$1.1T
$573K 0.07%
2,100
-3,000
-59% -$941K
NVCR icon
195
CALL
NovoCure
NVCR
$1.8B
$556K 0.07%
8,000
-39,700
-83% -$2.99M
TE
196
CALL
T1 Energy
TE
$1.18B
$547K 0.06%
80,000
-400
-0.5% -$3.5K
GOOGL icon
197
Alphabet (Google) Class A
GOOGL
$4.2T
$545K 0.06%
100,000
-80,000
-44% -$9.42M
MMSI icon
198
Merit Medical Systems
MMSI
$5.07B
$543K 0.06%
+10,000
New +$610K
GFF icon
199
CALL
Griffon
GFF
$3.99B
$541K 0.06%
+19,300
New +$487K
BEKE icon
200
PUT
KE Holdings
BEKE
$18.5B
$539K 0.06%
30,000
-176,000
-85% -$2.48M

Similar funds

SG3 Management's Q2 2022 Portfolio in Review

As of Q2 2022, SG3 Management held 1,001 positions worth $852M, down 76% from $3.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

SG3 Management withdrew a net $2.35B in Q2 2022, closing 613 positions and reducing 168 holdings. Its most notable exit was Amazon, an estimated $24.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, down from 2.5% a quarter earlier, followed by Energy and Technology.

Against the trend, SG3 Management opened a new position in KraneShares CSI China Internet ETF worth $6.55M.

  • SG3 Management's largest Q2 2022 buy was KraneShares CSI China Internet ETF: 200,000 shares worth $6.55M.
  • SG3 Management added most to Revolve Group in Q2 2022, an estimated $665K increase.
  • SG3 Management's biggest Q2 2022 reduction was Bausch Health, cutting an estimated $12.4M.
  • SG3 Management fully exited Amazon in Q2 2022, selling an estimated $24.8M.
  • SG3 Management's ten largest holdings make up 41% of its $852M portfolio in Q2 2022.
  • SG3 Management opened 100 new positions and closed 613 in Q2 2022.
  • SG3 Management's portfolio value fell 76% quarter-over-quarter to $852M.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.